Prosed/ DS

Quick links to important sections

Prosed/ DS

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Prosed/ DS

What is Prosed/DS? A Drug Identity Overview

Property Description
Active Ingredients Hyoscyamine, Methenamine, Methylene Blue, Sodium Biphosphate
Form Oral Tablet
Pharmacological Class Urinary Antispasmodic and Urinary Antiseptic
Common Use Management of urinary tract irritation symptoms
Origin Semi-synthetic (Hyoscyamine) and Synthetic (others)

What Type of Medicine is Prosed/DS and How is it Classified?

Prosed/DS is a prescription combination medicine taken via the oral route of administration as an oral tablet. This product is classified as a urinary antispasmodic and a urinary antiseptic/anti-infective, reflecting its multi-action approach to managing irritation in the lower urinary tract. The general classification indicates that the medicine is clinically recognized for its ability to both relax the urinary system and exert mild cleansing properties. As a combination drug, it integrates four distinct active ingredients. The origins are mixed, with the anticholinergic component Hyoscyamine being semi-synthetic, while the remaining agents are synthetic chemical entities.

Composition: The Four Active Components of the Prosed/DS Combination

The effectiveness of Prosed/DS is derived from the synergy of its four essential active ingredients: Hyoscyamine, Methenamine, Methylene Blue, and the acidifying agent, Sodium Biphosphate. Hyoscyamine serves as the antispasmodic, helping to relax the smooth muscles of the urinary tract. Methenamine provides the main antiseptic function, a mechanism that requires an acidic environment to release its therapeutic agent. This dependency necessitates the inclusion of Sodium Biphosphate as a urinary acidifier, ensuring the chemical conditions required for Methenamine’s full action. This deliberate four-component design provides comprehensive support not found in simpler urinary formulations.

General Purpose: Core Benefits of this Urological Agent

The general purpose is to provide comprehensive symptomatic management for discomfort and irritation. By combining an agent that reduces involuntary muscle spasms with components that maintain antiseptic conditions in the urine, the medicine offers a dual benefit. This multi-targeted approach is designed to specifically address the primary sources of irritation—both the muscular contractions and the microbial environment—helping to alleviate symptoms such as pain, burning, and the uncomfortable frequency associated with lower urinary tract irritation.

Regulatory References

  1. Methenamine - LiverTox

What side effects are possible with Prosed/ DS?

Possible Side Effects and Safety Information

The regulatory safety profile for this combination medicine is primarily characterized by the known effects of its anticholinergic component, Hyoscyamine, and the specific actions of its urinary antiseptic agents. The documented adverse reactions are categorized by the body systems they affect, reflecting the multi-component nature of the drug.

Adverse Reaction Classification by System

The official labeling notes that effects may involve several System-Organ Classes. Anticholinergic effects are commonly noted, including dry mouth, blurred vision, and increased heart rate (tachycardia). Other effects may involve the Nervous System (dizziness, headache, confusion), Gastrointestinal System (nausea, vomiting), and Skin (rash or allergic reactions).

An expected, non-harmful finding is the blue-to-blue-green discoloration of the urine, which is directly attributable to the Methylene Blue component.

Serious Safety Reactions and Constraints

Specific serious adverse reactions highlighted in regulatory warnings include the potential for acute urinary retention, particularly in patients with pre-existing conditions like prostatic hypertrophy or other forms of obstructive uropathy. Severe hypersensitivity reactions, such as those leading to angioedema or anaphylaxis, are also officially documented as requiring immediate attention.

Safety constraints restrict the use of this medicine under certain conditions, known as contraindications. These absolute restrictions include closed-angle glaucoma, myasthenia gravis, paralytic ileus, or severe hepatic or renal disease. Furthermore, the label advises caution for the older adult population, which may be more susceptible to the central nervous system effects of the anticholinergic component.

Overdose and Emergency Response

Overdose and When to Seek Help

This information is based strictly on authoritative government regulatory documents regarding the management of overexposure to this product.

If you suspect an overdose, seek immediate emergency medical assistance. The official regulatory guidance states that overexposure may lead to severe symptoms and requires urgent intervention by trained healthcare professionals.

Documented Overdose Manifestations

Overdose with this product is primarily associated with severe antimuscarinic symptoms resulting from the hyoscyamine component. The major physiological systems affected may include the Central Nervous System (CNS) and the Respiratory system.

Specific signs documented in regulatory profiles include:

  • Severe antimuscarinic symptoms
  • Excitement and seizures
  • Respiratory depression

Infants and young children are noted in regulatory warnings to be especially susceptible to the toxic effects of belladonna alkaloids, such as hyoscyamine.

Official Emergency Management

Management of overdosage described in official documents is symptomatic and supportive. It requires immediate medical procedures and the administration of prescription medications.

Required immediate actions and treatments cited in the official labeling include:

  • Measures to reduce absorption, such as gastric lavage or emesis.
  • Intravenous administration of physostigmine to reverse severe antimuscarinic symptoms.
  • Use of small doses of diazepam to control excitement and seizures.
  • Provision of artificial respiration with oxygen if respiratory depression is present.
  • Ensuring adequate hydration and other necessary symptomatic treatment.

Immediate medical care is required to carry out these essential procedures and manage potentially life-threatening outcomes.

Therapeutic Uses of Prosed/ DS

What Prosed/DS Treats: Main Uses and Benefits

Prosed/DS is a combination medication formulated to manage symptoms associated with lower urinary tract irritation. It is primarily used to provide relief from discomfort caused by diagnostic procedures or various inflammatory conditions of the urinary tract.

Therapeutic Indications

The medication is indicated for the treatment of local symptoms affecting the bladder and urethra. Its primary uses include:

  • Relief of Urinary Discomfort: It helps alleviate pain, burning sensations, and general discomfort often associated with hypermotility or inflammation of the urinary tract.
  • Management of Frequent Urination: The components of the medication work to reduce the urgency and frequency of urination by relaxing smooth muscles in the bladder.
  • Post-Procedural Recovery: It is frequently utilized to manage irritation following diagnostic examinations or surgical interventions involving the urinary tract, such as cystoscopy.

How Prosed/DS Provides Relief

Prosed/DS functions through a multi-action approach to address urinary symptoms. The combination of ingredients targets different aspects of urinary tract irritation:

  • Antispasmodic Action: By relaxing the smooth muscles of the urinary tract, the medication helps reduce cramping and the constant urge to urinate.
  • Antiseptic Properties: Some components provide a mild antiseptic effect within the urine, which helps maintain a cleaner environment in the urinary tract during irritation.
  • Acid-Base Balance: The formulation includes agents that can influence the pH of the urine, which may help in reducing the stinging or burning sensations experienced during urination.

Expected Benefits

The primary benefit of Prosed/DS is the improvement of quality of life for individuals experiencing acute urinary irritation. By addressing the physical sensations of pain and urgency, the medication allows for more comfortable daily functioning while the underlying cause of the irritation is being addressed or resolved.

Regulatory References

  1. NIH DailyMed

Eligibility and Restrictions for Use

Who Can and Cannot Use Prosed/DS? — Official Eligibility Summary

Eligibility for Prosed/DS is strictly defined by regulatory documents, focusing on absolute contraindications and population-specific restrictions.

Contraindications (Must Not Use)

Individuals who must not use Prosed/DS include those with a known hypersensitivity to any of its components, such as methenamine, hyoscyamine, or methylene blue. Use is also prohibited in patients with specific clinical conditions, including closed-angle glaucoma, myasthenia gravis, paralytic ileus, and obstructive uropathy or other forms of bladder neck obstruction.

Organ and Age Restrictions

The medication is contraindicated in patients with renal insufficiency or severe hepatic insufficiency due to impaired drug clearance.

Regulatory agencies state that the safety and efficacy of Prosed/DS are not established for use in children under 12 years of age. Use in the elderly requires caution, as these patients may be more sensitive to the anticholinergic effects of the drug.

For pregnancy, Prosed/DS is generally classified as Category C, meaning it should only be used if the potential benefit outweighs the potential risk. Caution is also advised when administering the drug to nursing mothers.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines the officially documented interaction patterns for Prosed/DS, as defined by government regulatory documents. The interactions are classified based on effects, required administration timing, and restricted combinations.


Documented Interaction Patterns

Classification Interacting Agents / Classes
Prohibited Combinations Sulfonamides, Urinary Alkalizers (including some Thiazide Diuretics)
Pharmacodynamic Effects Other Antimuscarinics, Opioid Analgesics, MAO Inhibitors, Serotonergic Psychiatric Medications
Pharmacokinetic Effects Antacids, Antidiarrheals, Other Oral Medications
Substance Interactions Ethanol (Alcohol)

Regulatory Constraints and Restrictions

Co-administration with Urinary Alkalizers is prohibited because they raise urine pH, which is officially documented to reduce the efficacy of the Methenamine component. Sulfonamides are also restricted due to the potential for a physicochemical interaction that can lead to crystalluria.

Timing-based constraints apply to agents that interfere with absorption: Antacids and Antidiarrheals must be administered with a separation of one hour from Prosed/DS doses. Additionally, Ketoconazole must be taken at least two hours after Prosed/DS to prevent reduced absorption caused by altered gastric pH.

Pharmacodynamic reinforcement is documented with Opioid Analgesics, increasing the risk of severe constipation, and with other antimuscarinics, intensifying antimuscarinic side effects. The Methylene Blue component necessitates a regulatory warning for Serotonin Syndrome risk when combined with serotonergic psychiatric medications.

Mechanism of Action

The mechanism is mediated by four active components that engage two primary, distinct mechanistic domains: Autonomic Nervous System signaling and the Chemical Environment of the urine.

The Antispasmodic Mechanism involves Hyoscyamine acting as a non-selective competitive antagonist at muscarinic acetylcholine receptors in the urinary bladder's detrusor muscle. By blocking the neurotransmitter acetylcholine, this mechanism interrupts the efferent signaling of the Parasympathetic Autonomic Nervous System that drives involuntary contraction, leading directly to the physiological consequence of reduced smooth muscle contraction.

The Antiseptic Mechanism is a synergistic cascade combining Methenamine and Sodium Biphosphate. Sodium Biphosphate chemically modulates the urine, ensuring an acidic pH ( pH le 6.0) required to trigger the acid-catalyzed hydrolysis of the prodrug Methenamine, liberating the antiseptic agent, Formaldehyde. Formaldehyde non-specifically denatures microbial macromolecules, resulting in a localized chemical inhibition of microbial viability. Methylene Blue provides an additional adjunctive mechanism through its redox activity and mild antiseptic properties. The overall physiological result is the product of these two complementary actions: neural pathway modulation and chemical agent release.

Dosage and Administration Information

Prosed/DS is a combination prescription medicine administered via the oral route as a double-strength tablet. The standard regimen for adult use is one tablet taken four times per day (Q.I.D.), taken at regular intervals to maintain consistent levels of the active ingredients.

A critical component of proper use is the administration requirement for fluid intake. Each dose must be swallowed and immediately followed by liberal fluid intake. Furthermore, the efficacy of the Methenamine component, which relies on chemical breakdown, is dependent on the maintenance of an acidic environment in the urine. This requirement is addressed by the inclusion of Sodium Biphosphate in the tablet's formulation.

The product is generally used for short-term symptomatic assistance and is not indicated for long-term use. Specific guidelines govern its use in younger populations: the medication is not recommended for children 6 years of age and younger. For children 7 years and older, the dosage must be individualized by a physician. A final procedural instruction related to the visible outcome of the treatment is that the Methylene Blue component will cause the urine to turn blue or blue-green, a consequence of the medication. Regarding missed doses, if a dose is skipped, patients are directed to take it as soon as possible, but explicitly not to double the dose if it is almost time for the next scheduled dose.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Prosed/DS

This overview summarizes the type of research and clinical findings related to the combination of Hyoscyamine, Methenamine, Methylene Blue, and Sodium Biphosphate, as reported in official and scientific sources. The overview describes the available research evidence and does not provide clinical guidance or treatment advice.


Evidence for Symptomatic Relief of Lower Urinary Tract Inflammation

Studies that were conducted, often historical or observational in nature, were used in research exploring how patient-reported outcomes related to physical discomfort change over time. These studies primarily focused on adults experiencing conditions characterized by functional limitations and outcomes linked to inflammatory or irritative states.

Research highlights changes measured during the study period related to irritative voiding symptoms, including the measurement of painful urination (dysuria), urinary urgency, and frequency. The available research structure often relies on historical evidence regarding the individual components and supportive clinical use data, rather than contemporary, large-scale, fixed-dose combination Randomized Controlled Trials (RCTs).


Evidence for Managing Bladder Muscle Spasms and Hypermotility

Research has primarily focused on the pharmacology of the antispasmodic component (Hyoscyamine) and the research examined its association with smooth muscle tissue. The studies explored subjective patient-reported experiences of muscle contractions and functional outcomes related to systemic or functional imbalance in the lower urinary tract. This research was evaluated in adults with symptoms associated with hypermotility.

Findings describing patterns observed in the studies are consistent with the expected short-term physiological effects of the antispasmodic agent. However, the degree of certainty varies across studies, as specific findings related to subgroups remain unclear. There is limited information for long-term outcomes available, as the research primarily examined short-term symptom changes related to acute or disruptive episodes.


Main Gaps and Uncertainties in the Evidence

A primary limitation is the lack of contemporary, high-quality, comparative evidence for the fixed-dose combination product. Much of the evidence relies on historical data and the established pharmacological activity of the individual components. Additionally, the follow-up durations were limited in many studies, contributing to uncertainty regarding extended or chronic use. Research involving specific subgroups, such as children ge 7 years and older adults, has been evaluated, but the dedicated research base for these age groups remains limited.

Key Studies & References

  1. DailyMed: URIN D/S - methenamine, sodium phosphate, monobasic, monohydrate, phenyl salicylate, methylene blue, and hyoscyamine sulfate tablet (Labeling for a similar combination product)
  2. HYOSCYAMINE SULFATE tablet (Single-agent component evidence, indications for spastic bladder, cystitis, etc.)
  3. Use of methenamine hippurate to prevent urinary tract infections in community adult women: a systematic review and meta-analysis (Supports Methenamine evidence quality and uncertainty)

Frequently Asked Questions (FAQ)

Common questions about Prosed/DS (FAQ)


Q: What is Prosed/DS used for?

According to the official product information, Prosed/DS is prescribed to relieve symptoms related to lower urinary tract irritation. These symptoms can include pain, urgency to urinate, frequency, and general discomfort that may occur due to infection, trauma, or surgery.


Q: How quickly does Prosed/DS start working?

Regulatory documents indicate that Prosed/DS is intended to provide rapid relief for symptoms of urinary tract irritation. The labeling indicates that because the medication acts locally on the urinary tract lining, symptom relief may be experienced relatively quickly, though individual response times can vary.


Q: How does Prosed/DS work to relieve urinary discomfort?

Studies and official information indicate that Prosed/DS contains multiple ingredients that act together. The components are described as having an antiseptic effect for local cleansing and an antispasmodic effect to potentially relax the smooth muscles of the urinary tract, which is intended to relieve associated spasms and pain.


Q: Is it safe to drive or operate machinery while taking Prosed/DS?

According to the regulatory sources, one of the components of Prosed/DS, hyoscyamine, may cause drowsiness or blurred vision in some patients. The official product information advises caution regarding activities requiring mental alertness, such as driving or operating machinery, until an individual observes their reaction to the medication.


Q: Can I drink alcohol while taking Prosed/DS?

Official product information advises caution regarding alcohol consumption while taking Prosed/DS. The labeling advises limiting or avoiding alcohol intake while using Prosed/DS, as alcohol may potentially enhance the sedative effects, such as drowsiness, caused by certain ingredients in the medication.


Q: Can Prosed/DS change the color of my urine?

Yes, official product information explicitly states that Prosed/DS contains a dye that may change the color of your urine to a blue or blue-green shade. This change is a known and anticipated effect caused by a specific dye within the formulation.


Q: Should Prosed/DS be taken with or without food?

Regulatory documents state that Prosed/DS may be taken with or without food. Taking it after meals is a common recommendation to minimize potential gastrointestinal discomfort, which is a possible side effect of some of the ingredients.


Q: Is Prosed/DS safe for the elderly?

Official prescribing information notes that older patients may exhibit increased sensitivity to the effects of the medication, particularly the anticholinergic ingredients. Therefore, regulatory information advises careful consideration for use in this population due to the potential for side effects such as confusion.


Q: Does Prosed/DS contain sulfa?

According to official product information, Prosed/DS does not contain a sulfa drug. Its main active ingredients are methenamine, methylene blue, phenyl salicylate, sodium biphosphate, and hyoscyamine.

How should Prosed/ DS be stored and disposed of?

Official Storage and Disposal Requirements

The storage of Prosed/DS tablets must adhere to the specific environmental and temperature constraints defined in the official regulatory labeling to ensure product quality.

Storage Component Requirement (Based on Official Labeling)
Temperature Store at Controlled Room Temperature, specifically between 15 and 30 C (59 to 86 F).
Protection The product must be kept in a dry place and the container must be tightly closed.
Child Safety KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN is a mandatory instruction.

No drug-specific disposal instructions are provided on the label; therefore, unused or expired medicine should be disposed of according to standard guidelines issued by local health authorities for non-hazardous pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Prosed/ DS found in:

A-Z Index: